FLUTICASONE FUROATE 0.0275%w/w IP + BENZALKONIUM CHLORIDE SOLUTION 0.015%w/w IP

A potent synthetic corticosteroid preparation that is an effective therapy for seasonal and perennial allergic rhinitis. (E O Meltzer, 1994) A topical intranasal corticosteroid with a potent anti-inflammatory activity that is effective in improving nasal symptoms of allergic rhinitis. (Pedro Giavina-Bianchi, 2008) An enhanced-affinity glucocorticoid with a potent anti-inflammatory activity that ameliorates the nasal and ocular symptoms of seasonal allergic rhinitis. (Glenis K Scadding, 2008) Provides relief from the discomfort and irritation in the nose caused due to allergies. Blocks certain chemical messengers' production that causes inflammation (redness and swelling) and allergies Provides comprehensive coverage of both nasal and ocular symptoms in seasonal allergic rhinitis caused by a variety of pollen types. (Anolik, 2010) A good therapeutic agent candidate for rhinitis treatment due to high topical potency and low potential for systemic effects. (Pedro Giavina-Bianchi, 2008) A good choice amongst available intranasal steroids and enhances patient satisfaction and compliance with the treatment. (R Kumar, 2012) A superior drug to second-generation antihistamines in the management of allergic rhinitis. (Foresi, 2000) Offers an effective and convenient treatment option in patients with seasonal and perennial allergic rhinitis. (H M Bryson, 1992) Produces sustained relief of symptoms, signs, and sensory attributes with a greater reduction in eosinophil count in comparison with azelastine hydrochloride in patients with allergic rhinitis. (Nandish Chennakeshavaraju, 2020)